
Layla D. Berry
Examiner (ID: 16889, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1609, 1623, 1693 |
| Total Applications | 1713 |
| Issued Applications | 1092 |
| Pending Applications | 106 |
| Abandoned Applications | 561 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17281683
[patent_doc_number] => 11198703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Process for the preparation of SGLT2 inhibitors and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 16/612028
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3153
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612028 | Process for the preparation of SGLT2 inhibitors and intermediates thereof | May 8, 2018 | Issued |
Array
(
[id] => 17922814
[patent_doc_number] => 11466047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Cyclic di-nucleotide compounds as sting agonists
[patent_app_type] => utility
[patent_app_number] => 16/611624
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31392
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611624 | Cyclic di-nucleotide compounds as sting agonists | May 6, 2018 | Issued |
Array
(
[id] => 13400063
[patent_doc_number] => 20180251574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => FUCAN-DENDRIMER BASED COMPOUNDS AND COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 15/970472
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970472
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970472 | FUCAN-DENDRIMER BASED COMPOUNDS AND COMPLEXES | May 2, 2018 | Abandoned |
Array
(
[id] => 18428700
[patent_doc_number] => 11673910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Macrolides with modified desosamine sugars and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/609120
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 63638
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609120 | Macrolides with modified desosamine sugars and uses thereof | Apr 26, 2018 | Issued |
Array
(
[id] => 16482410
[patent_doc_number] => 20200376010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => NUTRACEUTICAL AND/OR PHARMACEUTICAL COMPOSITION FOR STIMULATING THE PRODUCTION OF TYPE 2 BETA-DEFENSINS
[patent_app_type] => utility
[patent_app_number] => 16/607249
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607249 | Nutraceutical and/or pharmaceutical composition for stimulating the production of type 2 beta-defensins | Apr 25, 2018 | Issued |
Array
(
[id] => 18994590
[patent_doc_number] => 11911407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Therapies for cardiomyopathy
[patent_app_type] => utility
[patent_app_number] => 15/955628
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 29
[patent_no_of_words] => 14019
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955628
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955628 | Therapies for cardiomyopathy | Apr 16, 2018 | Issued |
Array
(
[id] => 13354589
[patent_doc_number] => 20180228834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS
[patent_app_type] => utility
[patent_app_number] => 15/951848
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15951848
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/951848 | PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS | Apr 11, 2018 | Abandoned |
Array
(
[id] => 15893611
[patent_doc_number] => 20200146324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => SULFITE-FREE, RAPID SETTING, THERMAL-REVERSIBLE MODIFIED POTATO STARCH GELLING AGENT AND PRODUCTS MADE THEREFROM
[patent_app_type] => utility
[patent_app_number] => 16/604521
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604521
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604521 | Sulfite-free, rapid setting, thermal-reversible modified potato starch gelling agent and products made therefrom | Apr 9, 2018 | Issued |
Array
(
[id] => 14069307
[patent_doc_number] => 20190083541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => ALKALIZED ORGANIC PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/948868
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15948868
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/948868 | ALKALIZED ORGANIC PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION | Apr 8, 2018 | Abandoned |
Array
(
[id] => 15435353
[patent_doc_number] => 20200031860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => BETA-NICOTINATE ESTER NUCLEOTIDES AND PROCESS FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/603164
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603164 | b-nicotinate ester nucleotides and process for preparing same | Apr 4, 2018 | Issued |
Array
(
[id] => 13493011
[patent_doc_number] => 20180298048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => MACROLIDES AND METHODS OF THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 15/946658
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946658
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946658 | Macrolides and methods of their preparation and use | Apr 4, 2018 | Issued |
Array
(
[id] => 14158695
[patent_doc_number] => 20190106450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => Mannose Derivatives for Treating Bacterial Infections
[patent_app_type] => utility
[patent_app_number] => 15/945221
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/945221 | Mannose derivatives for treating bacterial infections | Apr 3, 2018 | Issued |
Array
(
[id] => 15243413
[patent_doc_number] => 10507216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Method for olfactory improvement with saccharide
[patent_app_type] => utility
[patent_app_number] => 15/943400
[patent_app_country] => US
[patent_app_date] => 2018-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 5243
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15943400
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/943400 | Method for olfactory improvement with saccharide | Apr 1, 2018 | Issued |
Array
(
[id] => 13339747
[patent_doc_number] => 20180221413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => Glycosaminoglycan Compositions and Methods for Treating Connective Tissue Damage
[patent_app_type] => utility
[patent_app_number] => 15/928509
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15928509
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/928509 | Glycosaminoglycan Compositions and Methods for Treating Connective Tissue Damage | Mar 21, 2018 | Abandoned |
Array
(
[id] => 18103532
[patent_doc_number] => 11543414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Methods to improve reduction or labeling of carbohydrates
[patent_app_type] => utility
[patent_app_number] => 16/494992
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22298
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 292
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494992 | Methods to improve reduction or labeling of carbohydrates | Mar 21, 2018 | Issued |
Array
(
[id] => 16498860
[patent_doc_number] => 10864227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Enzymatic preparation of increased anticoagulant bovine sourced heparin
[patent_app_type] => utility
[patent_app_number] => 16/496149
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 2130
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496149
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496149 | Enzymatic preparation of increased anticoagulant bovine sourced heparin | Mar 19, 2018 | Issued |
Array
(
[id] => 18544201
[patent_doc_number] => 11717532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Methods and compositions for treating wounds utilizing chitosan compounds
[patent_app_type] => utility
[patent_app_number] => 15/923696
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 50321
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923696 | Methods and compositions for treating wounds utilizing chitosan compounds | Mar 15, 2018 | Issued |
Array
(
[id] => 15618809
[patent_doc_number] => 20200079809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/493732
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493732
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493732 | Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof | Mar 14, 2018 | Issued |
Array
(
[id] => 16648685
[patent_doc_number] => 10925839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Composition for treating joint disease and kit containing same
[patent_app_type] => utility
[patent_app_number] => 16/492365
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11972
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492365 | Composition for treating joint disease and kit containing same | Mar 13, 2018 | Issued |
Array
(
[id] => 15975707
[patent_doc_number] => 10668155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Hyaluronic acid stabilizer
[patent_app_type] => utility
[patent_app_number] => 15/917919
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9539
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917919
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/917919 | Hyaluronic acid stabilizer | Mar 11, 2018 | Issued |